The evolution from single-plate to multi-plate processing represents one of the most significant efficiency gains in modern analytical laboratories. As sample volumes continue to increase across pharmaceutical, clinical, and research environments, laboratories are discovering that traditional plate evaporation systems have become a critical bottleneck in their workflows. The introduction of triple-plate evaporation technology is fundamentally changing how laboratories approach high-throughput sample preparation, delivering unprecedented productivity gains.
The inability to process multiple plates simultaneously meant that laboratories faced significant time constraints when dealing with large sample batches. For high-throughput analytical workflows processing hundreds or thousands of samples, this sequential processing created substantial delays and resource allocation challenges.
The system's solid aluminum heating units provide consistent temperature distribution across all three plates, ensuring uniform evaporation rates throughout the entire process. This consistency is critical for maintaining analytical reproducibility across large sample batches.
Each 96-needle manifold is equipped with its own toggle switch to shut down gas flow when all three microplates are not in use, providing significant nitrogen gas conservation. This feature saves laboratories substantial money on gas consumption, as unused manifolds don't continuously consume nitrogen during partial-load operations. The ability to selectively operate one, two, or all three manifolds provides exceptional flexibility for varying sample loads.
The triple-plate system provides unprecedented flexibility in managing varying sample loads. Laboratories can operate the system with one plate during low-volume periods, two plates during moderate demand, or all three plates during peak throughput requirements. This scalability allows laboratories to optimize their workflows based on daily, weekly, or monthly sample volume fluctuations without requiring multiple separate evaporators.
Researchers focused on developing and validating an extraction protocol using a 96-well plate-based system to quantify PFAS in human milk samples [1]. Their goal was to improve scalability and reduce manual handling compared to traditional methods that require large sample volumes and labor-intensive preparation.
The methodology involved several key steps using microplate technology:
- Protein Precipitation: 300μL samples were vortexed with acetonitrile containing 1% formic acid and then centrifuged to separate the proteins from the supernatant.
- Matrix Removal: Filter plates were washed with 1:1 methanol/acetonitrile containing 1% formic acid, equilibrated using a small amount of the supernatant, and then loaded with 1 mL of the supernatant. Ammonium hydroxide was added to the extract for a final concentration of 0.03%.
- Evaporation and Reconstitution: Samples were dried completely at 50°C and reconstituted with 20:80 water/methanol for LC-HRMS analysis [1].
The 96-well microplate format serves several essential functions in this PFAS analysis workflow:
- Standardization and Reproducibility: The uniform well geometry and automated liquid handling capabilities ensure consistent sample treatment across all positions, critical for maintaining analytical precision when processing large sample batches.
- Resource Efficiency: The microplate format minimizes reagent consumption per sample while maximizing the number of samples that can be processed simultaneously, making it particularly valuable for studies requiring analysis of numerous human milk samples.
The evaporation step serves multiple critical analytical purposes in this PFAS extraction workflow:
- Sample Concentration: Evaporating samples to dryness at 50°C enables PFAS compounds to be concentrated from the original extraction volume, enhancing analyte detection sensitivity.
- Solvent Exchange: The evaporation and reconstitution process enables a complete solvent change from the extraction solvents (acetonitrile/methanol mixture) to the final LC-MS compatible solvent system (20:80 water/methanol), optimizing the sample for chromatographic analysis.
- Matrix Interference Removal: The controlled evaporation process helps eliminate residual acetonitrile that could interfere with mass spectrometric detection, ensuring cleaner analytical results.
The method demonstrated excellent analytical performance with method detection limits (MDLs) ranging from 0.5 to 27 pg/mL for the PFAS compounds analyzed. The researchers achieved impressive recovery rates and successfully detected PFAS in human milk samples, with the method showing high sensitivity for the developed approach.
The study found that 11 compounds had MDLs below 1 pg/mL, and 23 compounds had MDLs below 10 pg/mL, demonstrating the method's capability to detect PFAS at environmentally and toxicologically relevant concentrations. The microplate-based approach proved particularly valuable for handling the complex matrix of human milk while maintaining analytical sensitivity [1].
This semi-automated microplate-based method represents a significant advancement in PFAS biomonitoring capabilities. The ability to process large numbers of human milk samples efficiently is crucial for epidemiological studies investigating PFAS exposure patterns and health outcomes in vulnerable populations, particularly nursing mothers and infants. The method's high throughput capabilities enable researchers to conduct comprehensive exposure assessments that would be impractical with traditional analytical approaches.
The integration of microplate technology with right size plate evaporation systems demonstrates how modern laboratory automation can transform environmental health research by making large-scale biomonitoring studies more feasible and cost-effective while maintaining analytical rigor.
For pharmaceutical laboratories conducting drug metabolism and pharmacokinetics (DMPK) studies, the ability to process three plates simultaneously transforms analytical workflows. Large bioanalytical studies that previously required multiple days of evaporation can now be completed in a single day, dramatically accelerating drug development timelines.
In pharmacokinetics, microplate evaporation is often used to prepare human plasma samples for LC-MS/MS analysis. For instance, in a recent study published in Molecules, researchers investigated the bioavailability of mangiferin from mango leaf extracts. Following protein precipitation, a MICROVAP was used to remove acetonitrile from plasma samples in a 96 well plate format ahead of a solvent exchange to a methanol/water mixture [2].
In another study, researchers used a MICROVAP to quantify sarmentosin levels in plasma after consumption of blackcurrant juice or powder. Samples were applied to a Phree plate for phospholipid removal and then evaporated to dryness under nitrogen at 35 °C in the MICROVAP [3]. The nitrogen concentrator provided gentle, uniform evaporation across all wells, critical for preserving analyte integrity and ensuring consistent sample recovery prior to LC-MS analysis.
Clinical laboratories processing patient samples and forensic laboratories analyzing evidence samples benefit enormously from the tripled throughput. The ability to maintain consistent conditions across all three plates ensures that analytical results remain comparable regardless of which plate position samples occupy.
Millennium Health, a leading clinical toxicology lab, relies on Organomation’s triple‑plate MICROVAP to significantly boost the throughput and reproducibility of preparing urine and oral fluid samples for drug testing. Because these drug testing results tend to be available by the next business day, specimens must be processed quickly. The lab utilizes multiple triple plate units each day to ensure the samples are prepared quickly and reliably, without sacrificing analytical quality.
Citations: